Company / Return on Assets (ROA)
Orchestra BioMed Holdings, Inc. Return on Assets (ROA) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-53.1%
FY2025
5-year range
-64.5% / -35.3%
FY2023-FY2025
Trend
+17.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -35.3% to -53.1% over the past 2 years.
Based on SEC 10-K filings.
-53.1% in FY2025.
Declined from -35.3% to -53.1% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 17.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -53.1% | +17.6% |
| FY2024 | -64.5% | -82.7% |
| FY2023 | -35.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026